Remote Tai Chi for Knee Osteoarthritis
TAICHIKNEE
2 other identifiers
interventional
480
1 country
1
Brief Summary
The goal of this pragmatic randomized trial is to evaluate the effectiveness of remote Tai Chi to treat knee pain in adults with knee osteoarthritis. The main questions the trial aims to answer are:
- Compared to routine care, will patients with Knee OA receiving remote Tai Chi exhibit greater improvement in knee-related pain (WOMAC pain score, primary outcome), pain interference (PROMIS-Pain Interference, secondary outcome), and health-related quality of life at 3 months?
- Does remote tai chi decreases healthcare utilization and analgesic use over the one-year study period? Researchers will compare remote Tai Chi added to routine care to routine care alone to see if remote tai chi works to treat knee osteoarthritis pain. Participants will participate in remotely delivered web-based tai chi sessions, twice a week for 12 weeks, or will continue to receive routine care. Participants will be followed for 12 months after randomization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Apr 2025
Longer than P75 for not_applicable knee-osteoarthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedStudy Start
First participant enrolled
April 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
July 8, 2025
July 1, 2025
2.7 years
March 26, 2024
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
WOMAC Pain Score
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm.
3 months from randomization
Secondary Outcomes (3)
PROMIS Pain Interference score
3 months from randomization
SF-12 PCS score
3 months from randomization
Number of knee joint injections
12 months from randomization
Other Outcomes (37)
WOMAC Pain Score
6 months from randomization
WOMAC Pain Score
12 months from randomization
PROMIS Pain Interference score
6 months from randomization
- +34 more other outcomes
Study Arms (2)
Tai Chi + Routine Care
EXPERIMENTALThe intervention will be delivered via a HIPAA-secure web-based video platform. All remote Tai Chi sessions will be 60 minutes, twice a week, for 3 months. All program components will use the Yang style Tai Chi, and every session will include warm up, review of principles, meditation with movement, breathing techniques and relaxation.
Routine Care
NO INTERVENTIONParticipants will be encouraged to continue their ongoing care for Knee OA by their providers. In addition, primary care providers and other participating clinicians in the health system will receive information from the study team on routine care or "2019 ACR Guideline-Based Care." At the end of the 12-month trial period, routine care participants will be offered access to recordings for the full 3-month Tai Chi program (24 sessions).
Interventions
Tai Chi mind-body exercise is a complex, multi-component nonpharmacological intervention integrating physical, psychological, emotional, and behavioral elements.
Eligibility Criteria
You may qualify if:
- Age 50 years or older
- Treating clinician diagnosis of knee osteoarthritis
- Have a score of 40 (visual analog version) or greater on at least 1 of the 5 questions in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale (range of 0 to 100, with higher scores indicating greater pain) at baseline.
- Able to provide informed consent
- If randomized to the Routine Care group, willing to abstain from Tai Chi programs until completion of the study
- If randomized to the Tai Chi group, willing to comply with the Tai Chi program (twice-a-week remote sessions for 12 weeks)
- Has access to a home computer or device that will allow telehealth (bidirectional audio and video) delivery of the intervention
- Is an active patient at one of the 4 participating healthcare system
You may not qualify if:
- Currently practicing Tai Chi
- Serious medical conditions (e.g., dementia, significant neurological deficits or neurodegenerative disorder, active cancer treatment, psychosis, sensory deficits) limiting the participant's ability to participate in the Tai Chi safely, as determined by the principal investigators
- Unable to walk without a cane or other assistive device
- Any previous or scheduled knee replacement
- Reports severe depression defined by a Beck Depression Inventory (BDI-II) score of 29 or more.
- Reports suicidal ideations defined by a score on BDI-II item of 2 or 3 ('I would like to kill myself' or 'I would kill myself if I had the chance').
- Not English speaking
- Enrollment in any other clinical trial within the last 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tufts Medical Centerlead
- Boston Medical Centercollaborator
- University of California, Los Angelescollaborator
- The Cleveland Cliniccollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
Study Sites (1)
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chenchen Wang, MD, MSc
Tufts Medical Center
- PRINCIPAL INVESTIGATOR
Robert Saper, MD, MPH
The Cleveland Clinic
- PRINCIPAL INVESTIGATOR
Eric Roseen, DC, PhD
Boston Medical Center
- PRINCIPAL INVESTIGATOR
Helen Lavetrsky, MD, MS
University of California, Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 25, 2024
Study Start
April 7, 2025
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
August 31, 2028
Last Updated
July 8, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- The time of results publication or the end of the funding period.
This study will submit and share de-identified individual patient data as described in our Data Management and Sharing Plan and will follow NIH policies for data sharing